EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bayesian Optimization for Efficient Multiobjective Formulation Development of Biologics

Isabel Waibel iD, Timo N Schneider iD, Fiona J Fischer, Poonpat Dumnoenchanvanit, Alina Kulakova, Tin Duy Nguyen, Thomas Egebjerg, Søren Bertelsen iD, Nikolai Lorenzen iD, Paolo Arosio

Molecular Pharmaceutics · 03.11.2025 · 22 (11) · 6636-6645

DOI: 10.1021/acs.molpharmaceut.5c00591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.09.2025. Verfasst von Isabel Waibel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zürich, Vladimir-Prelog-Weg 1-5/10, Zürich 8093, Swit…. Hauptthemen laut MEDLINE: Biological Products, Antibodies, Monoclonal, Drug Compounding, Chemistry, Pharmaceutical. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsAntibodies, MonoclonalDrug CompoundingChemistry, PharmaceuticalBayes TheoremExcipientsMachine LearningHydrogen-Ion Concentration

Stichwörter der Autor:innen

Bayesian optimizationdevelopabilityexcipientsmachine learningmonoclonal antibodiesmultiobjective optimizationprotein formulation

Substanzen

Biological ProductsExcipientsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zürich, Vladimir-Prelog-Weg 1-5/10, Zürich 8093, Switzerland.
  • Novo Nordisk A/S, Therapeutics Discovery, Novo Nordisk Park, Måløv 2760, Denmark.
  • Novo Nordisk A/S, Digital Science & Innovation, Novo Nordisk Park, Måløv 2760, Denmark.

ORCID-Profile: Isabel Waibel, Timo N Schneider, Søren Bertelsen, Nikolai Lorenzen

Zitieren

APA

Waibel, I., Schneider, T. N., Fischer, F. J., Dumnoenchanvanit, P., Kulakova, A., Nguyen, T. D., Egebjerg, T., Bertelsen, S., Lorenzen, N., & Arosio, P. (2025). Bayesian Optimization for Efficient Multiobjective Formulation Development of Biologics. Molecular Pharmaceutics, 22(11), 6636-6645. https://doi.org/10.1021/acs.molpharmaceut.5c00591

Vancouver

Waibel I, Schneider TN, Fischer FJ, Dumnoenchanvanit P, Kulakova A, Nguyen TD, et al. Bayesian Optimization for Efficient Multiobjective Formulation Development of Biologics. Molecular Pharmaceutics. 2025;22(11):6636-6645. doi:10.1021/acs.molpharmaceut.5c00591

BibTeX
@article{Waibel2025,
  author = {Waibel, Isabel and Schneider, Timo N and Fischer, Fiona J and Dumnoenchanvanit, Poonpat and Kulakova, Alina and Nguyen, Tin Duy and Egebjerg, Thomas and Bertelsen, Søren and Lorenzen, Nikolai and Arosio, Paolo},
  title = {Bayesian Optimization for Efficient Multiobjective Formulation Development of Biologics},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {11},
  pages = {6636--6645},
  doi = {10.1021/acs.molpharmaceut.5c00591}
}
Kostenlos starten →